Clorox reported a decrease in sales and diluted net earnings per share for the fourth quarter. Sales were down 9%, and diluted EPS decreased by 68%. The company faced challenges including decelerating shipments from peak pandemic levels, unfavorable price mix, and increased costs.
Sales decreased by 9% due to lower shipments and unfavorable price mix.
Diluted EPS decreased by 68% due to lower sales and increased costs.
Gross margin decreased significantly due to higher manufacturing, logistics, and commodity costs.
The company is focused on operational execution, margin rebuilding, and market share improvements for fiscal year 2022.
Clorox projects fiscal year 2022 sales to be down 2% to 6% and diluted EPS to be between $5.05 and $5.35. Adjusted EPS is projected to be between $5.40 and $5.70.
Visualization of income flow from segment revenue to net income